Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEO

 Novo Nordisk ‌plans to ​seek Chinese regulatory approval for ‌its ⁠weight-loss pill "very soon," ⁠CEO Mike ​Doustdar ​said ​Tuesday, in ‌a move to catch up with ‌rival ​Eli ​Lilly ​in ‌the world's second-largest ​pharmaceutical ​market

https://www.aol.com/articles/novo-nordisk-seek-regulatory-approval-060006000.html